JPRN-UMIN000011669招募中未知
Phase II study of the 2nd line Nab-PTX/CBDCA combination therapy for advanced non-small cell lung cancer which is previously treated with platinum-based chemotherapy - Phase II Study of Nab-PTX/CBDCA for NSCLC previously treated with platinum
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Symptomatic brain metastasis 2) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy 3) With active double cancer or multicentric cancer 4) Treated with radiotherapy within the past four weeks. 5) With a history of the treatment with taxane. 6) With clinically important complications. 7) Interstitial pneumonia or pulmonary fibrosis becomes the clinical problem 8) With pleural effusion or pericardial effusion accumulates which need drainage 9) With the history of hypersensivity for nab-paclitaxel, CBDCA 10) Main organs had a serious medical risk factor, and the physicians judged treatment not to be safe. 11) Physician concludes that the patient's participation in this trial is inappropriate
研究者
相似试验
招募中
不适用
Phase II study of more than second-line Nab-PTX for advanced non-small cell lung cancer which is previously treated with chemotherapynon-small cell lung cancerJPRN-UMIN000011823Incorporated Administrative Agency National Hospital Organization Nishigunma National Hospital37
已完成
2 期
Phase II clinical study of nab-PTX/CBDCA (administer 3-weeks on / 1-week off) for patients with clinical stage IIIB/IV or recurrent NSCLClung cancerJPRN-UMIN000016255Shiga University of Medical Science5
已完成
不适用
Phase2 study of dose dense EC followed Nab-PTXas neoadjuvant chemotherapy for HER2-negative primary breast cancerbreast cancerJPRN-UMIN000020693Kyoto Prefectural University of Medicine50
招募中
2 期
In patients with previously untreated early stage triple negative breast cancer, how well does using Nivolumab or Nivolumab + Relatlimab before starting standard chemotherapy, OR starting treatment with Nivolumab and chemotherapy at the same time, help to reduce tumour size before surgery compared?Triple negative breast cancerCancer - BreastACTRN12619001308189Breast Cancer Trials162
已完成
2 期
Phase 2 study of 2nd line dose-escalated nab-Paclitaxel for advanced or recurrent gastric cancer (KGSG1301)Advanced or recurrent gastric cancerJPRN-UMIN000024333Graduate School of Medical Science, Kumamoto Universit45